Please login to the form below

Not currently logged in
Email:
Password:

The Carlyle Group appoints Essner

The Carlyle Group, a global private equity firm, has appointed former Wyeth CEO, Robert Essner, as senior advisor to its global healthcare group

The Carlyle Group, a global private equity firm, has appointed Robert Essner, former CEO and chairman of the board at Wyeth, as senior advisor to its global healthcare group.

Essner will provide strategic guidance to Carlyle professionals throughout the healthcare investment process, from sourcing to purchasing, and advise portfolio company executives on management, operational and growth strategies. He joins a group of talented senior executives who serve as Carlyle Senior Advisors across a spectrum of industries.

Karen Bechtel, Carlyle MD and head of the global healthcare group, said: "Bob's leadership experience and value creation abilities will add to the depth and scope of our ability to find and make compelling investments in the global healthcare space. We are so pleased he has agreed to be a part of our group."

Essner said: "I am excited to join Carlyle and partner with the Carlyle healthcare team. We see a range of opportunities in the US and globally for private capital to help strengthen and improve the efficiency and effectiveness of the healthcare sector."

Essner served at Wyeth from 1989-2008, where he led Wyeth's transformation into a global leader in biotechnology and vaccines. He worked his way up from senior vice president, sales and marketing to CEO and chairman.

8th April 2010

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Dr Henry Skinner
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
By Henry Skinner, Chief Executive Officer of the AMR Action Fund...
Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...